Alberta Investment Management Corp (AIMCo)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.6M Hold
442,000
0.37% 41
2025
Q4
$54.3M Hold
442,000
0.32% 56
2025
Q3
$49.1M Sell
442,000
-46,296
-9% -$5.26M 0.35% 47
2025
Q2
$54.1M Sell
488,296
-29,802
-6% -$3.17M 0.42% 41
2025
Q1
$58.1M Sell
518,098
-231,902
-31% -$23.9M 0.4% 46
2024
Q4
$69.3M Sell
750,000
-151,193
-17% -$13.6M 0.46% 34
2024
Q3
$75.6M Buy
901,193
+910
+0.1% +$69.4K 0.65% 30
2024
Q2
$61.8M Buy
900,283
+82,900
+10% +$5.53M 0.65% 28
2024
Q1
$59.9M Hold
817,383
0.61% 33
2023
Q4
$66.2M Hold
817,383
0.62% 32
2023
Q3
$61.3M Sell
817,383
-99,591
-11% -$7.66M 0.66% 32
2023
Q2
$70.7M Hold
916,974
0.68% 29
2023
Q1
$76.1M Sell
916,974
-310,217
-25% -$25.7M 0.74% 29
2022
Q4
$105M Sell
1,227,191
-54,406
-4% -$4.31M 0.93% 17
2022
Q3
$79.1M Sell
1,281,597
-10,800
-0.8% -$681K 0.61% 29
2022
Q2
$79.9M Buy
1,292,397
+145,383
+13% +$9M 0.57% 33
2022
Q1
$68.2M Buy
1,147,014
+174,100
+18% +$11.1M 0.39% 46
2021
Q4
$70.6M Buy
972,914
+124,231
+15% +$8.56M 0.43% 47
2021
Q3
$59.3M Sell
848,683
-87,400
-9% -$6.14M 0.51% 37
2021
Q2
$64.5M Sell
936,083
-48,300
-5% -$3.23M 0.54% 40
2021
Q1
$63.6M Buy
984,383
+53,500
+6% +$3.45M 0.57% 40
2020
Q4
$54.2M Buy
930,883
+59,700
+7% +$3.6M 0.48% 49
2020
Q3
$55M Buy
871,183
+90,200
+12% +$6.26M 0.6% 33
2020
Q2
$60.1M Buy
780,983
+172,900
+28% +$13.3M 0.72% 23
2020
Q1
$45.5M Sell
608,083
-150,100
-20% -$10.4M 0.81% 20
2019
Q4
$49.3M Sell
758,183
-413,600
-35% -$26.9M 0.42% 59
2019
Q3
$74.3M Buy
1,171,783
+176,300
+18% +$11.5M 0.7% 25
2019
Q2
$67.3M Buy
995,483
+338,700
+52% +$22.3M 0.61% 29
2019
Q1
$42.7M Buy
656,783
+102,700
+19% +$6.83M 0.4% 57
2018
Q4
$34.7M Buy
554,083
+271,000
+96% +$18.9M 0.37% 62
2018
Q3
$21.9M Buy
283,083
+49,600
+21% +$3.75M 0.19% 131
2018
Q2
$16.5M Hold
233,483
0.14% 159
2018
Q1
$17.6M Hold
233,483
0.16% 154
2017
Q4
$16.7M Sell
233,483
-21,500
-8% -$1.63M 0.15% 158
2017
Q3
$20.7M Buy
254,983
+1,100
+0.4% +$84.1K 0.19% 125
2017
Q2
$18M Buy
253,883
+90,983
+56% +$6.05M 0.17% 143
2017
Q1
$11.1M Buy
162,900
+147,400
+951% +$10.4M 0.1% 197
2016
Q4
$1.11M Buy
15,500
+1,700
+12% +$126K 0.01% 528
2016
Q3
$1.09M Sell
13,800
-2,700
-16% -$219K 0.01% 527
2016
Q2
$1.38M Sell
16,500
-330,600
-95% -$29.3M 0.02% 472
2016
Q1
$31.9M Hold
347,100
0.42% 47
2015
Q4
$35.1M Sell
347,100
-19,400
-5% -$2.02M 0.41% 47
2015
Q3
$36M Buy
+366,500
New +$40.7M 0.42% 41
2015
Q1
Sell
-304,500
Closed -$28.7M 530
2014
Q4
$28.7M Hold
304,500
0.3% 72
2014
Q3
$32.4M Hold
304,500
0.34% 60
2014
Q2
$25.2M Buy
304,500
+253,300
+495% +$19.7M 0.27% 82
2014
Q1
$3.63M Buy
51,200
+30,600
+149% +$2.4M 0.04% 384
2013
Q4
$1.55M Buy
+20,600
New +$1.43M 0.02% 411
2013
Q3
Sell
-12,000
Closed -$647K 460
2013
Q2
$647K Buy
+12,000
New +$625K 0.02% 270

Other funds holding GILD

Alberta Investment Management Corp (AIMCo)'s GILD Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) held its Gilead Sciences (GILD) position steady in Q1 2026 at 442,000 shares worth $61.6M. The position accounts for 0.37% of the portfolio, ranked #41.

Alberta Investment Management Corp (AIMCo) first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $105M in Q4 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Alberta Investment Management Corp (AIMCo) held 442,000 shares of Gilead Sciences worth $61.6M as of Q1 2026.
  • Alberta Investment Management Corp (AIMCo) left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.37% of Alberta Investment Management Corp (AIMCo)'s portfolio in Q1 2026, its #41 holding.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
  • Alberta Investment Management Corp (AIMCo)'s Gilead Sciences position peaked at $105M in Q4 2022.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.